Claudia Seitz studied law at the Universities of Freiburg, Basel and Strasbourg with additional studies in Helsinki and Florence. After the First State Law Examination in 1996, she worked as a trainee in the cabinet of the German judge at the European Court of Justice in Luxembourg.

Besides her academic career, Claudia Seitz has extensive practical expertise and experience of more than 25 years as Attorney-at-Law in private practice, as Inhouse Counsel at an international life sciences company and as Scientific Advisor and Expert for Courts and International Organizations.

After her legal clerkship (Referendariat) and the Second State Examination in 1998 and admission to the bar in Cologne, she worked as an associate at the international law firm Cleary Gottlieb in Brussels from 1998 to 1999 before she became Attorney-at-Law and one of the partners of the life sciences law firm Seitz & Riemer, founded in 1999.

She received her doctorate (Dr. iur.) in European Law from the University of Basel in 2001. From 2002 to 2009 she worked as Inhouse Counsel for an international life sciences company in Basel. In parallel, she completed postgraduate studies at King's College London from 2006 to 2007 and a master programme from 2008 to 2009 and received a master's degree (Master in Arts, M.A.) in 2009. Since 2007, she is a Lecturer at the Department of Public Law of the University of Basel. From 2012 to 2014 Claudia Seitz was appointed at Scientific Advisor at the Swiss Federal Administrative Court in St. Gallen.

From 2014 to 2019, she was the Max Geldner Assistant Professor at the University of Basel and a co-founder of the Center for Life Sciences Law (CLSL) at the Law Faculty.

Since 2019, she is a Visiting Professor at University of Ghent as well as a Lecturer at the Law Faculties of the Universities of Basel and Bonn and, since 2021, also UFL.

Claudia Seitz completed her habilitation at the University of Basel with the habilitation thesis «Health and the State». In 2022 she was awarded the venia legendi for public law, European law, public international law and life sciences law. In 2023, she received a second master's degree (Executive Master in Law and AI) from the Brussels School of Competition Law (BSC Brussels).

In early 2023, Claudia Seitz was appointed as the Professor of Public Law, European Law, Public International Law and Life Sciences Law at the UFL. In 2024 she was also a Visiting Professor at the Bina Nusantara (BINUS) University in Jakarta, Indonesia.

Claudia Seitz is teaching and researching in particular in European law, public international law, life sciences law and the law of new technologies.

She is a member of the scientific editorial and advisory board of several law journals such as the European Pharmaceutical Law Review (EPRL) since 2014 and the Europäische Zeitschrift für Wirtschaftsrecht (EuZW) since 2010. In addition, she is also a regular speaker at international conferences and the author of several books, commentaries and over 100 publications in national and international law journals.

Claudia Seitz is the Head of the Institute of European and International Law (IEIL).

List of publications

(as of 10/2025)

I. Monographs

1. Health and the State – Regulations for the Protection of Health in the Life Sciences (postdoctoral thesis), in preparation for printing, approx. 900 pages

2. Repetitorium Gesundheitsrecht (Health Law Revision Guide), Orell Füssli Verlag, Zurich 2023, 350 pages

3. Tables on Administrative Law, Helbing Lichtenhahn Verlag, Basel 2017, 329 pages

4. Praxis des Europarechts – Grundrechtsschutz (Practice of European Law – Protection of Fundamental Rights), Schulthess Verlag/Carl Heymanns Verlag/Verlag Österreich, Zurich/Basel/Geneva/Cologne/Vienna 2006 (with S. Breitenmoser and B. Riemer), 643 pages

5. One-stop shop and subsidiarity: An investigation of the referral procedure under Article 9 of the European Merger Regulation, doctoral thesis, University of Basel, series of publications by the Research Institute for Economic Constitution and Competition (FIW), Volume 187, Carl Heymanns Verlag, Cologne/Berlin/Bonn/Munich, 2002, 305 pages
 

II. Smaller monographs and publications

1. Food and Feed Code (LFGB), 4th edition, Behr's Verlag, Hamburg 2023 (with B. Riemer), 106 pages

2. Food Labelling Law, 4th edition, Behr's Verlag, Hamburg 2021 (with B. Riemer), 174 pages

3. Priorities and Policy Ideas for Digital Sequence Information from the Scientific Perspective, online publication by the Leibniz Institute Braunschweig 2020, (with A. Scholz Hartman, U. Hillebrand, J. Freitag, I. Cancio, C. dos Santos Ribeiro, G. Cochrane, G. Haringhuizen, P. Oldham, S. Devanshi, T. Thiele and E. van Zimmeren), 49 pages

4. Food and Feed Code (LFGB), 3rd edition, Behr's Verlag, Hamburg 2016 (with B. Riemer), 96 pages

5. Food Labelling Law (taking into account the Food Information Regulation), 3rd edition, Behr's Verlag, Hamburg 2014 (with B. Riemer), 148 pages

6. Food Labelling Law (taking into account the Food Information Regulation), 2nd edition, Behr's Verlag, Hamburg 2012 (with B. Riemer), 75 pages

7. Guide to M&A and Merger Control, Verlag Linde International, Vienna 2011 (with D. Seckler), 128 pages

8. Food and Feed Code (LFGB), 2nd edition, Behr's Verlag, Hamburg 2010 (with B. Riemer), 95 pages

9. Food Labelling Law, 1st edition, Behr's Verlag, Hamburg 2007 (with B. Riemer), 75 pages

10. The New Food, Commodities and Feed Code (LFGB), 1st edition, Behr's Verlag, Hamburg 2005 (with B. Riemer), 80 pages

11. Guide to Food Law Practice, German Association for Food Law and Food Science (BLL), Bonn 2003 (with M. Welsch, K.-H. Kühn and B. Riemer), 56 pages
 

III. Commentaries

1. Commentaries on Art. 32 PatG (expropriation of the patent) and Art. 37, 38, 39, 40, 40a, 40b, 40c, 40d and 40e PatG (action for the granting of a licence and cancellation of the patent, as well as licences in the public interest and compulsory licences, inter alia for diagnostic agents and for the export of pharmaceutical products), in: Schweizer/Zech (eds.), SHK Commentary on the Patent Act, 2nd edition, Stämpfli Verlag, Bern, in preparation

2. Commentaries on Art. 13, Art. 14, Preliminary Remarks Art. 17 ff. Regulation 1/2003, and Art. 17 Regulation 1/2003 (investigative powers in EU competition law) in: Berg/Mäsch (eds.), German and European Antitrust Law, Commentary, 5th ed., Luchterhand Verlag/Verlag Wolters Kluwer, Munich, in press (with R. van der Hout)

3. Comments on the preliminary remarks §§ 81-96, §§ 81, 81a, 81b, 81c, 81d, 81 e, 81f, 81g, 81h, 81i, 81j, 81k, 81l, 81m, 81n, 82, 82a, 83, 84, 85, 86, 86a GWB (fine proceedings in competition matters, leniency proceedings) and Art. 13, Art. 14, preliminary remarks Art. 17 ff. Regulation 1/2003, and Art. 17 Regulation 1/2003 (investigative powers in EU competition law) in: Berg/Mäsch (eds.), German and European Antitrust Law, Commentary, 4th ed., Luchterhand Verlag/Verlag Wolters Kluwer, Munich 2022 (preliminary remarks on Sections 81-96, Sections 81-86a GWB with B. Riemer, preliminary remarks on Article 17 Regulation 1/2003, Articles 13-15 and Article 17 Regulation 1/2003 with R. van der Hout)

4. Commentaries on Art. 16a, 16b and 16c HMG (revocation, transfer, renewal and review of marketing authorisation), in: Eichenberger/Jaisli/Richli (eds.), Basler Kommentar zum Heilmittelgesetz, Helbing Lichtenhahn Verlag, Basel 2021 (with C. Conti and D. Feitzinger)

5. Commentaries on Art. 32 PatG (expropriation of the patent) and Art. 37, 38, 39, 40, 40a, 40b, 40c, 40d and 40e PatG (action for the granting of a licence and cancellation of the patent, as well as licences in the public interest and compulsory licences, e.g. for diagnostics and for the export of pharmaceutical products), in: Schweizer/Zech (eds.), SHK Commentary on the Patent Act, Stämpfli Verlag, Bern 2019

6. Commentaries on the preliminary remarks §§ 81-96, §§ 81, 81a, 81b, 82, 82a, 83, 84, 85, 86, 86a GWB (fine proceedings in competition matters), §§ 87, 88, 89, 89a, 89b, 89c, 89d, 89e, 90, 90a, 91, 92, 93, 94 and 95 GWB (civil disputes) and preliminary remarks Art. 17 ff. Regulation 1/2003 (investigative powers in EU competition law) in: Berg/Mäsch (eds.), German and European Antitrust Law, Commentary, 3rd ed., Luchterhand Verlag/Verlag Wolters Kluwer, Munich 2018 (preliminary remarks Art. 17 Regulation 1/2003 Regulation 1/2003 with R. van der Hout)

7. Commentary on the chapter ‘Protection of Secrets’, in: Metzger/Zech (eds.), Plant Variety Rights, Commentary, C. H. Beck Verlag, Munich 2016 (with M. Kock)

8. Commentaries on the preliminary remarks. §§ 81-96 GWB (fine proceedings in competition matters), §§ §§ 87, 88, 89, 89a, 89b, 89c, 89d, 89e, 90, 90a, 91, 92, 93, 94 and 95 GWB (civil disputes) (ed.), German and European Antitrust Law, Commentary, 2nd edition, Luchterhand Verlag/Verlag Wolters Kluwer, Munich 2015

9. Commentaries on the chapters ‘Compliance for Food Companies’ and ‘European and German Product Liability Law’, in: Riemer (ed.), Practical Handbook on Food Packaging and Food Contact Materials, loose-leaf collection, Chapter 4, Behr's Verlag, Hamburg since 2012

10. Commentary on the preliminary remarks to Sections 81-96 GWB (fine proceedings in competition matters), Sections 87, 88, 89, 89a, 89b, 89c, 89d, 89e, 90, 90a, 91, 92, 93, 94 and 95 GWB (Civil disputes) in: Mäsch (ed.), Practical commentary on German and European antitrust law, 1st edition, Lexis Nexis, Münster 2010
 

IV. Editorship

1. Legal Protection in Theory and Practice, Liber Amicorum for Stephan Breitenmoser on his retirement from the Faculty of Law at the University of Basel, Helbing Lichtenhahn Verlag, Basel 2022 (with R. Straub and R. Weyeneth), 1447 pages

2. Anwaltsgeheimnis – Legal Privilege, Helbing Lichtenhahn Verlag, Basel 2019 (with W. Wohlers), 221 pages
 

V. Essays and contributions to anthologies

1. Climate and Environmental Law and its Mechanisms for Sustainable Policies from a European Perspective: Challenges for the Implementation of the Green Deal, European Integration Studies 2024, in press

2. Fundamental Rights Protection and Artificial Intelligence – The European Union's AI Act and the Council of Europe's AI Convention, EuZW 2024, 836-845

3. Digital Health Data and the European Health Data Space: Legal Issues Concerning the Primary and Secondary Use of Health Data, in: Epiney/Theuerkauf-Progin (eds.), Swiss Yearbook for European Law (SJER) 2023/2024, Stämpfli Verlag, Bern/Zurich/Basel/Geneva 2024

4. Bedside manufacturing as the next step in personalised medicine: Medical progress and legal challenges, Oxford Academic, Journal of Law and the Biosciences 2024 (open access) (with T. El Saadany, C. Bräm and T. Szucs)

5. Drug and medical device law: authorisation and conformity assessment procedures, document protection, patent protection and supplementary protection certificates, Therapeutische Umschau (TU), special issue on medical law, TU 2024, 153-162

6. Digital Health Data and the Digital Health Revolution – Some Reflections on the Primary and Secondary Use of Health Data in the Light of the European Health Data Space, in: Kalliopi Th. Kipouridou/Maria M. Milapidou (eds.), ‘Ευρωπαϊκό Χώρο Υγεία: Προοπτικές και προκλήσει – European Health Law: Perspectives and Challenges’, Conference Proceedings, AUTh Laboratory for the Research of Medical Law and Bioethics, Athens 2024, 27-54

7. New genomic techniques in plant breeding – Current state of regulation, EuZW 2024, 489/490

8. State aid as an instrument of the Green Deal for climate and environmental protection – The EU's Green Deal Industrial Plan and state aid from EU Member States, in: Epiney/Theuerkauf-Progin (eds.), Swiss Yearbook of European Law (SJER) 2022/2023, Stämpfli Verlag, Bern/Zurich/Basel/Geneva 2023, 319-334

9. The European Health Union and the Protection of Public Health in the European Union: Is the European Union prepared for future Cross-Border Health Threats?, ERA Forum 2023 (open access)

10. The European Health Union as a joint response to cross-border health risks in light of the Covid-19 pandemic, EuZ 2022, 1-32 (open access)

11. Dynamics, time and law: Dynamic legal interpretation in the context of new technologies?, in: Seitz/Straub/Weyeneth (eds.), Legal Protection in Theory and Practice, Liber Amicorum for Stephan Breitenmoser on his retirement from the Faculty of Law at the University of Basel, Helbing Lichtenhahn Verlag Basel 2022, 259-270

12. State financing of important projects of common European interest and the European Health Union – New developments following the IPCEI Communication in EU state aid law for EU projects on health protection, in: Epiney/Theuerkauf-Progin (eds.), Swiss Yearbook for European Law (SJER) 2021/2022, Stämpfli Verlag, Bern/Zurich/Basel/Geneva 2022, 341-351

13. Potential Benefits of Genome Editing and the Unknown Risk – Regulation of Genome Editing and other New Breeding Techniques in Light of the Precautionary Principle and Irreversibility, in: Spranger (ed.), Genome Editing under Gene Technology Law – Legal Aspects and Latest Developments, Berlin 2021, 100-119

14. EU state aid law after one year of the coronavirus crisis: vaccination or overdose? An overview, in: Epiney/Zlătescu (eds.), Swiss Yearbook for European Law (SJER) 2020/2021, Stämpfli Verlag, Bern/Zurich/Basel/Geneva 2021, 507-524 (with A. Berne)

15. Digitalised healthcare – Legal aspects, tribune 2021, 4/5

16. Lost on the High Seas without a Safe Harbour or a Shield? – Navigating Cross-Border Data Transfers in the Pharmaceutical Sector after Schrems II Invalidation of the EU-US Privacy, EPRL 2020, 153-160 (with M. Corrales Compagnucci T. Minssen, M. Aboy)

17. Covid-19 and digitalisation – The importance of genetic resources and digital sequence information for research, EuZW 2020, 729-731

18. Genetic Material and Sequence Data to protect Global Health in the Light of Pandemic Outbreaks: Mapping the Legal Landscape under European and International Law, EJHL 2020, 233-341

19. Protection against epidemics and pandemics in the European Union – The coronavirus hCoV-19 as a test case for health protection?, EuZW 2020, 449-453

20. EU State Aid Law and the Coronavirus Crisis – EU Regulations on Supporting the Economy in Times of Pandemic, in: Epiney/Zlătescu (eds.), Swiss Yearbook for European Law (SJER) 2019/2020, Stämpfli Verlag, Bern/Zurich/Basel/Geneva 2020, 393-426 (with A. Berne)

21. Digital Sequence Information – Legal Questions for Transparency, Sharing and Protection, in: Sabran/Lestari/Satyawan/Hadiarto/Mastur/Terryana/Badan Penelitian (eds.), Boosting the Big Data of Plants with Digital Identifiers, Jakarta 2020, 171-182

22. The Panacea for COVID-19: EU State Aid Law – State Support Measures and the EU Commission's Temporary Framework for State Aid, EuZW 2020, 591-598 (with A. Berne)

23. The EU-US Privacy Shield Regime for Cross-Border Transfers of Personal Data under the GDPR – What are the Legal Challenges and how might these affect Cloud-Based Technologies, Big Data, and AI in the Medical Sector?, EPRL 2020, 34-50 (with T. Minssen, M. Aboy and M. Corrales Compagnucci)

24. Editorial: Multiple Factors indicate that Big Data, Artificial Intelligence and Machine Learning will play a Crucial Role in the Evolution of Pharmaceutical Innovation, EPRL 2019, 139-141 (with T. Minssen)

25. The Draft Institutional Agreement between Switzerland and the EU – An Initial Analysis of the State Aid Provisions, EuZW 2019, 594-600 (with A. Berne)

26. Recent developments in European state aid law, taking into account the institutional framework agreement between Switzerland and the European Union, in: Epiney/Hehemann/Zlătescu (eds.), Swiss Yearbook for European Law (SJER) 2018/2019, Stämpfli Verlag, Bern/Zurich/Basel/Geneva 2019, 413-454 (with A. Berne)

27. Legal privilege in European law – overview of the legal situation and the case law of the EU courts, in: Seitz/Wohlers (eds.), Anwaltsgeheimnis – Legal Privilege, Helbing Lichtenhahn Verlag Basel, 2019, 145-171 (with A. Berne)

28. Dynamics in biotechnological progress – dynamics in law too?, EuZW 2019, 1/2

29. Healthcare Systems and Competition Law: Challenges and Boundaries for the Application of Competition Law in the EU Healthcare Sector, in: Nihoul/van Cleynenbreugel (eds.), The Roles of Innovation in Competition Law Analysis, Edward Elgar Verlag, Cheltenham 2018, 131-161

30. Health protection in international law and its implementation by the federal government and cantons – On the regulation and scope of medical care for refugees and the protection of their health, Asyl 4/2018, 2018, 3-7

31. Legal issues in the context of the digital transformation of healthcare, Swiss Medical Forum – Swiss Medical Forum 2018, 101-105 (with M. Bischofsberger, A. Wicki, C. Lovis, M. de Geyter and J. Eckstein)

32. The Geneva Convention on Refugees, the Dublin Regulation and the right to health in the refugee debate, in: Breitenmoser/Uebersax (eds.), Schengen and Dublin – Current Issues in Practice / Le Chantier Schenge et Dublin – Questions Actuelles de la Pratique, Dike/Nomos/Manz, Zurich/St. Gallen/Baden-Baden/Vienna 2018, 357–419

33. Modified or not? – Regulatory legal issues concerning genetic optimisation through new biotechnological processes, EuZW 2018, 757-764

34. Big Data in the Pharmaceutical Sector – Current Developments and Legal Challenges, in: Vermeulen/Lievens (eds.), Data Protection and Privacy under Pressure – Transatlantic Tensions, EU Surveillance and Big Data, Maklu Verlag, Antwerp/Apeldoorn/Portland 2017, 293-309

35. Chapter ‘Pay for Delay Agreements,’ in: Duncan/Zech (eds.), Handbook on IP and Life Sciences, Papers of the International Conference on IP and Life Sciences of the Faculty of Law of the University of Basel in collaboration with Queen Mary, University of London, Edward Elgar Publishing, Cheltenham, 2017, 451-467

36. Patent Settlements and Pay for Delay Agreements in the Pharmaceutical Industry – Legal Situation after the Lundbeck Judgment, EuZW 2016, 856-859

37. International Convergence and Standardisation of Compliance Management: From Compliance Programme to Compliance Management System, in: Gallmann/Gersbach (eds.), Der Unternehmensjurist: Ein Handbuch für die Praxis, Schulthess Verlag, Zurich 2016, 204-214 (with D. Bühr)

38. The concept of state aid in European state aid law – The new communication from the European Commission on the concept of state aid in the context of the modernisation of EU state aid law, in: Epiney/Hehemann (eds.), Swiss Yearbook for European Law (SJER) 2015/2016, Stämpfli Verlag, Bern/Zurich/Basel/Geneva 2016, 325-340

39. The new EU framework for state aid for research, development and innovation and its significance for the pharmaceutical sector, in: Epiney/Hehemann (eds.), Swiss Yearbook for European Law (SJER) 2014/2015, Stämpfli Verlag, Bern/Zurich/Basel/Geneva 2015, 371-384

40. Protection of fundamental rights through procedural law – The fundamental right to good administration and European administrative procedural law, EuZW anniversary issue, EuZW 2015, 273-276

41. From Compliance Programme to Compliance Management Systems: International Convergence and Standardisation, Business Compliance 02/2015, 28-32 (with D. Bühr)

42. Energy and environmental subsidies in EU state aid law, taking into account international requirements of the Framework Convention on Climate Change and the Kyoto Protocol, in Epiney/Diezig (eds.), Swiss Yearbook for European Law (SJER) 2013/2014, Stämpfli Verlag, Zurich/Basel/Geneva 2014, 257-272 (with S. Breitenmoser)

43. The principle of effective judicial protection and the power of review in the system of judicial control – The judgment of the Court of Justice of the European Union in the Telefónica case, EuZW 2014, 774-776

44. Food and free competition: Overview of current developments and trends at national and European level, Behr's Yearbook for the Food Industry 2015, Hamburg 2014, 53-61

45. Authorisations issued by the Swiss Agency for Therapeutic Products (Swissmedic) may, after recognition in Liechtenstein, be considered as the first authorisation for the marketing of a medicinal product in the EU, EWS 2014, 89-91

46. Economic Principles in Antitrust Law in the Aftermath of the More Economic Approach: General Aspects, Current Issues and Recent Developments, in: Mathis (ed.), Law and Economics in Europe: Foundations and Applications, Proceedings of the Law and Economic Conference 2012, Springer Verlag, Berlin 2013, 367-387

47. State aid law principles for research funding in the European Union, Germany and Switzerland, in: Epiney/Diezig (eds.), Swiss Yearbook for European Law (SJER) 2012/2013, Stämpfli Verlag, Bern/Zurich/Basel/Geneva 2013, 167-182 (with S. Breitenmoser)

48. The new EU Cosmetics Regulation and the precautionary principle for a higher level of product safety and health protection – cosmetics as distinct from medicinal products and medical devices and requirements for placing them on the market, Journal of European Food Law 2013, 142-146

49. New ways to effective legal protection in the EU, EuZW 2013, 562/562

50. Clear boundaries and minefields: Market abuse control in the pharmaceutical sector following the AstraZeneca ruling by the Court of Justice of the European Union, EuZW 2013, 377-380

51. Legal developments for services of general economic interest in European state aid law: New quality framework of the European Commission with special consideration of investment promotion in the hospital sector, in: Epiney/Fasnacht (eds.), Swiss Yearbook for European Law (SJER) 2011/2012, Stämpfli Verlag, Bern/Zurich/Basel/Geneva 2012, 239-253 (with S. Breitenmoser)

52. ‘Autonomous implementation’: Swiss commercial law between harmonisation and independence, EuZW 2012, 841-843 (with W. A. Stoffel)

53. Competition law aspects of plant variety protection and patent licences in the seed sector (Part II): Structure, restrictions and legal requirements for property right licences in the field of patent and plant variety protection, GRUR Int. 2012, 868-880 (with M. Kock)

54. Competition law aspects of plant variety protection and patent licences in the seed sector (Part I): Property right licences between plant variety protection, patent law and antitrust requirements, GRUR Int. 2012, 711-720 (with M. Kock)

55. Public over Private Enforcement of Competition Law? Has the issue of access to leniency documents for the preparation of antitrust damages claims now been resolved?, GRUR-RR 2012, 137-142

56. The food sector and competition authorities: New investigations and activities by the Federal Cartel Office, the European Commission and the network of European competition authorities in the food trade, Journal of European Food Law 2012, 65-67

57. The Cartel Procedure Regulation 1/2003 in a ‘field trial’ in practice: Some research findings on experimental purposes, uncontrolled growth and resistance in European cartel procedure law, in: Müller-Graff/Schwarze (eds.), New European Economic and Competition Law? , Nomos Verlag, Baden-Baden 2011, European Law (EuR), Supplement 2, 71-100

58. Economic Approaches in European State Aid Law, in: Epiney/Fasnacht (eds.), Swiss Yearbook for European Law (SJER) 2010/2011, Stämpfli Verlag Bern/Zurich/Basel/Geneva 2011, 445-460 (with S. Breitenmoser)

59. The establishment of a European patent court system and the future of the EU patent, EWS 2011, 112

60. Principles of pricing between manufacturers and retailers according to the guidelines of the Federal Cartel Office: Risks, Pitfalls and Practical Advice, Journal of European Food Law 2011, 116-121

61. One Step in the Right Direction: The New Horizontal Guidelines and the Restated Block Exemption Regulations, JECLAP 2011, 452-462

62. Antitrust violations and their consequences: New legal developments regarding bonus programmes, the right of injured parties to inspect files and recommendations for practice, Journal of European Food Law 2011, 169-173

63. Origin, validity and scope of attorney-client privilege in European competition law: The current status of legal professional privilege in light of the protection of fundamental rights in European antitrust proceedings, in: Weiß (ed.), The legal status of affected parties in modernised EU antitrust proceedings, Studies in International Business Law, Lectures from the 1st Speyer Antitrust Law Forum of the German University of Administrative Sciences Speyer, Nomos Verlag, Baden-Baden 2010, 93-113

64. Swiss subsidy law in light of EU state aid law and WTO subsidy law, in: Epiney/Gammenthaler (eds.), Swiss Yearbook of European Law (SJER) 2009/2010, Stämpfli Verlag, Bern/Zurich/Basel/Geneva 2010, 139-165 (with S. Breitenmoser)

65. Scope and protection of the European Biopatent Directive: On the protection of a patent for the DNA sequence of a biotechnological invention, EuZW 2010, 366/367

66. One step forward and two steps back? On the latest status of attorney-client privilege for corporate lawyers in European antitrust proceedings, EuZW 2010, 524-526

67. Editorial: No legal privilege for in-house lawyers: a Pyrrhic victory?, EuZW 2010, 761

68. The European Life Science Law and the Protection of Biotechnological Inventions: New Developments for Patent Protection under the European Biotechnology Directive, ELR 2010, 276-280

69. New developments in European life science law on the functional limitation of DNA-based biotechnology patents, ZLR 2010, 226/227

70. Fundamental rights guarantees in antitrust sanction proceedings: Fundamental case law of the Swiss Federal Administrative Court on the observance of fundamental rights under the ECHR in antitrust fine proceedings, EuZW 2010, 292-296

71. The Health Claims Regulation in judicial practice, Magazine for Organic and General Food Law 2010, 84-87 (with B. Riemer)

72. The scope of the Free Trade Agreement between Switzerland and the European Community: Latest case law of the European Court of Justice and its significance for Switzerland, ELR 2009, 97-101

73. Procedural public policy and the right to a fair trial under Article 6 of the ECHR: Recognition and enforcement of judgments and exclusion from proceedings for failure to comply with a court order, ELR 2009, 274-279

74. European state aid law in times of crisis, in: Epiney/Gammenthaler (eds.), Swiss Yearbook for European Law (SJER) 2008/2009, Stämpfli Verlag, Bern/Zurich/Basel/Geneva 2009, 107-126 (with B. Riemer and S. Breitenmoser)

75. Prevention – Sanctions – Protection of Fundamental Rights: Preventing Violations of Competition Law Standards in Companies, in: Wolf/Hürzeler/Mona (eds.), Prevention in Law, Verlag Helbing Lichtenhahn, Basel/Geneva/Munich 2008, 311-331

76. Recent developments in European state aid procedural law, in: Epiney/Civitella (eds.), Swiss Yearbook for European Law (SJER) 2007/2008, Stämpfli Verlag Bern/Zurich/Basel/Geneva 2008, 143-163 (with S. Breitenmoser)

77. Economic analysis and risk distribution: Specification of the conditions for claims for damages in the event of an unlawful prohibition of a merger, EuZW 2008, 719/720

78. Principles of sound administration and equal treatment: Reduction of sanctions due to non-compliance with procedural guarantees applicable under Community law by the European Commission, EuZW 2008, 525-528

79. Confidentiality protection for lawyer correspondence in European competition proceedings: On the scope and structure of lawyer-client privilege according to new European case law, EuZW 2008, 204-208

80. Latest developments in the recovery of state aid in European competition law, in: Epiney/Wyssling (eds.), Swiss Yearbook for European Law (SJER) 2006/2007, Stämpfli Verlag, Bern/Zurich/Basel/Geneva 2007, 173-190 (with S. Breitenmoser)

81. Claim for damages by a company due to the unlawful prohibition of a merger by the European Commission, EuZW 2007, 659-663

82. Tougher sanctions for violations of European antitrust law, EuZW 2007, 304-305

83. Autonomy of regions in tax regulations: Recent developments in European state aid law and their significance for Switzerland, AJP 2007, 415-423

84. Dawn raids in European antitrust proceedings: requirements for the necessity and specificity of review decisions, WuW 2007, 716-726 (with W. Berg and J. Lohrberg)

85. Latest developments in the recovery of state aid under European competition law, in: Epiney/Wyssling (eds.), Swiss Yearbook for European Law (SJER) 2006/2007, Stämpfli Verlag, Bern/Zurich/Basel/Geneva 2007, 173-190 (with S. Breitenmoser)

86. European state aid law in the area of tax breaks, in: Epiney/Egbuna-Joss/Wyssling (eds.), Swiss Yearbook for European Law (SJER) 2005/2006, Stämpfli Verlag, Bern/Zurich/Basel/Geneva 2006, 159-175 (with S. Breitenmoser)

87. EC state aid law and state financing of tasks in the public interest, in: Epiney/Rivière/Theuerkauf/Wyssling (eds.), Swiss Yearbook for European Law (SJER) 2004/2005, Stämpfli Verlag, Bern/Zurich/Basel/Geneva 2005, 129-140 (with S. Breitenmoser)

88. State aid law in the aviation sector, in: Epiney/Theuerkauf/Rivière (eds.), Swiss Yearbook for European Law (SJER) 2003, Stämpfli Verlag, Bern/Zurich/Basel/Geneva 2004, 197-214 (with S. Breitenmoser)

89. Corporate lawyers and legal privilege in European competition proceedings: Change in European case law?, EuZW 2004, 231-235

90. Parallel merger control proceedings in Switzerland and the European Communities, WuW 2001, 126-133

91. Residues of environmental chemicals and pesticides in foodstuffs and their assessment by the ECJ, ZLR 2000, 466-474 (with B. Riemer)

VI. Judgment notes

1. Pharmaceutical law: Distribution of non-prescription medicines via platforms in the EU – ‘Doctipharma SAS/Union des Groupements de pharmaciens d´officines (UDGPO)’, EuZW 2024, 434/435

2. Antitrust law: Invoking a patent that has been declared invalid in the first instance is only contrary to antitrust law in exceptional cases, GRUR Prax 2020, 198

3. Health/cosmetics law: Sales ban on cosmetics tested on animals – ‘European Federation for Cosmetic Ingredients/Secretary of State for Business, Innovation and Skills’, EuZW 2016, 830
 

• Publikationsverzeichnis
• Vortragsverzeichnis